CDSCO issues alert on these Medical Devices

CDSCO has clarified that it has not received any complaints from the market on this issue.

223
CDSCO DCGI FDA

Last Updated on June 23, 2022 by The Health Master

Download Medical Device Alert dated 14-06-2022The Central Drugs Standard Control Organisation (CDSCO) has issued an alert notice, vide Medical Device Alert dated 14-06-2022, on US medical technology major Medtronic’s DST series EEA auto suture circular stapler and loading unit with DST Series technology stapler used in open and laparoscopic surgeries as a glitch could result in various adverse impacts to the patients.

The DST Series EEA stapler is used throughout the alimentary tract for the creation of end-to-end, end-to-side, and side-to-side anastomoses in both open and laparoscopic surgeries.

The company, which issued a Field Safety Corrective Action Notification informed CDSCO that the 25 mm EEA Auto Suture circular staplers with DST Series Technology, with model numbers EEA25, EEAXL25, EEA2535 and EEAXL2535, have the potential for the staple guide to not be securely attached to the instrument.

This issue is related only to the 25 mm EEA auto suture circular staplers with DST Series Technology and not other Medtronic products or other sizes of EEA auto suture circular staplers with DST Series Technology are affected by this issue, it said.

A staple guide not attached to the instruments could cause the component to disengage and if disengaged, could allow the device to transect tissue without forming staples.

This could result in delay of treatment, extended hospital stays, unspecified tissue injury, unintended radiation exposure, unexpected medical intervention, foreign body in patient, failure to anastomose and hemorrhagic, it added.

CDSCO has clarified that it has not received any complaints from the market on this issue.

The product, manufactured in its Covidien manufacturing site in US, and imported by India Medtronic Pvt Ltd between June 201 and February 2022 and supplied in the country between June 2017 and May, 2022, are expected to be in the radar of the affected units.

Medtronic has informed the regulator that a voluntary Corrective Action will be implemented to communicate the issue to all consignees who have received affected products, based on the company records, and they will be asked to confirm receipt of FCA notification.

The Consignees, including Medtronic field representatives, will be asked to return all unused affected sold product within their possession.

Licensing procedure for Medical devices

Latest Notifications: Medical Devices

Classifications of Medical Devices under the provisions of MDR 2017

FAQs on Medical Devices Rules, 2017   

FAQs – on Blood Pressure Monitoring Devices

FAQs – on Blood Bags and its Testing

USFDA approves drug for Alopecia, includes safety warning too

NPPA to track availability of Essential Drugs across the country

Phase I Clinical Trial Centres to be developed: ICMR

Topical steroid: Types, uses, side effects and treatment, revealed by doctors

Pharma Industry urges IPC regarding DT time of Soft Gelatin Capsules: Read

USFDA issues draft norms on Antibacterial therapies

Online sale of medicines will promote these issues related to Medicines

Allow private practice or 50% non-practice allowance: Doctors

Drug recall: Over 6 lakh bottles of Blood Pressure treatment tablets recalled

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner